STAGE III NON-SMALL-CELL LUNG CANCER
Clinical trials for STAGE III NON-SMALL-CELL LUNG CANCER explained in plain language.
Never miss a new study
Get alerted when new STAGE III NON-SMALL-CELL LUNG CANCER trials appear
Sign up with your email to follow new studies for STAGE III NON-SMALL-CELL LUNG CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Double-Punch combo trial aims to keep advanced lung cancer at bay
Disease control CompletedThis study tested if adding a precise, high-dose radiation treatment (SBRT) to an immunotherapy drug (durvalumab) could better control stage 3 lung cancer after patients finished standard chemotherapy and radiation. The goal was to see if damaging the tumor with SBRT makes the im…
Matched conditions: STAGE III NON-SMALL-CELL LUNG CANCER
Phase: PHASE2 • Sponsor: Brown University • Aim: Disease control
Last updated Apr 04, 2026 00:36 UTC
-
New drug duo tested in fight against tough cancers
Disease control CompletedThis study tested whether combining an experimental drug (sEphB4-HSA) with an approved immunotherapy (pembrolizumab) could help control advanced lung or head/neck cancers that had worsened after standard chemotherapy. It involved 42 patients who received both drugs by IV infusion…
Matched conditions: STAGE III NON-SMALL-CELL LUNG CANCER
Phase: PHASE2 • Sponsor: University of Southern California • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC